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Abstract
Background: There exists abundant molecular and ultra-structural evidence to suggest that
cytoplasmic actin can physically interact with the nuclear envelope (NE) membrane system.
However, this interaction has yet to be characterised in living interphase cells.
Results: Using a fluorescent conjugate of the actin binding drug cytochalasin D (CD-BODIPY) we
provide evidence that polymerising actin accumulates in vicinity to the NE. In addition, both
transiently expressed fluorescent actin and cytoplasmic micro-injection of fluorescent actin
resulted in accumulation of actin at the NE-membrane. Consistent with the idea that the
cytoplasmic phase of NE-membranes can support this novel pool of perinuclear actin
polymerisation we show that isolated, intact, differentiated primary hepatocyte nuclei support actin
polymerisation in vitro. Further this phenomenon was inhibited by treatments hindering steric
access to outer-nuclear-membrane proteins (e.g. wheat germ agglutinin, anti-nesprin and anti-
nucleoporin antibodies).
Conclusion: We conclude that actin polymerisation occurs around interphase nuclei of living cells
at the cytoplasmic phase of NE-membranes.
Background
The nuclear envelope (NE) consists of two adjacent mem-
branes, the inner (INM) and the outer nuclear membrane
(ONM). The ONM is functionally connected to the endo-
plasmic-reticulum (ER) and contains numerous ribos-
omes, while the INM contains a unique set of
transmembrane proteins and maintains close contact
with chromatin in the nuclear matrix through the nuclear
lamina network [1,2]. The ONM/ER comprising a single
continuous membrane system is connected to the INM
through nuclear pore complexes (NPC), which constitute
the unique gateway for macromolecular transport across
the nuclear-cytoplasmic boundary [3,4]. The cytoskeletal
protein actin may play a role in NE function. This view has
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received support from recent evidence suggesting that the
NE-membrane system is physically connected to the cyto-
plasmic microfilament network. For example, ONM pro-
teins containing giant spectrin repeats or SUN (for Sad1p,
UNC-84 homology) domains are involved in nuclear
anchorage and migration, probably via actin filament
interactions [5,6]. In metazoan cells, the integral ONM
protein nesprin (member of the Syne/ANC-1 protein fam-
ily) contains an α-actinin like actin-binding domain
potentially capable to link the NE-membrane to the cyto-
plasmic actin cytoskeleton [7].
Actin is a highly conserved cytoskeletal protein that is dis-
tributed in a dynamic equilibrium between the ~42 kD
monomeric (G-actin) and the filamentous polymerised
(F-actin) forms. Actin's endogenous, polymeric properties
are preserved in vitro and have been extensively character-
ised [8,9]. Polymerisation occurs at the so-called critical
concentration, where non-covalent interactions overcome
a rate limiting step yielding trimeric nucleation complexes
to which monomers associate spontaneously and seed fil-
ament growth [10]. Inside living cells, the non-steady-
state dynamics of actin polymerisation are highly regu-
lated by an array of actin binding proteins (for review see
[11-13]). Actin binding proteins regulate changes in
actin's polymerisation state within functional sub-cellular
domains or compartments allowing for actin's role in a
variety of cellular processes as diverse as signal transduc-
tion and cell motility. Importantly, the ONM protein
nesprin enhances actin polymerisation rates, shortens fil-
ament elongation times, and increases filament bundling
in vitro. Therefore, it has been hypothesised that nesprin
(or other cytoskeletal microfilament binding ONM pro-
teins) can recruit actin to the cytoplasmic ONM interface
[7].
Previously, ultra-structural studies using electron micros-
copy in fixed material have demonstrated "filament-like"
networks continuous with the NE-membrane and NPC
[14,15]. Moreover, light microscopic studies have
reported a fine perinuclear "shell" of actin filaments
around the nuclei of fixed cultured cells [16]. In the cur-
rent study we visualised actin polymerisation in proximity
to the NE-membrane inside living cells. This approach has
been technically challenging, in part because the compart-
mentalised gradient is expected to be small (compared
with large backgrounds coming from actin involved in
other processes). We overcame these difficulties, using a
variety of fluorescent probes for actin and confocal fluo-
rescence imaging methods. We report perinuclear actin
inside intact living cells during interphase, and we provide
evidence that perinuclear actin polymerisation involves
binding at the ONM of the NE-membrane.
Results
Cytochalasin D binds NE-membranes
Actin binding drugs alter the gross shape of cell nuclei in
eukaryotic cells during interphase. In untreated HeLa cells
(or those treated with DMSO vehicle) we noticed that the
nuclear shape (revealed by Hoechst staining) was in gen-
eral characterised by a smooth, round shape, whereas
~20% of the nuclei were irregular in shape. Irregular
nuclei were characterised by asymmetric abnormalities
including lobes and/or invaginations. In HeLa cells
treated for thirty minutes with the actin binding drugs lan-
truculin A (LatA), cytochalasin D (CD) or jasplakinolide
(Jaspl) a significant two-to four-fold increase in the per-
centage of cells displaying NE-membrane irregularities
was observed (fig.1A; see also fig.1B for an example of
cells after the respective treatment). Of the drugs tested,
CD was of particular interest. This fungal metabolite
binds the free-barbed-end of actin filaments and thereby
blocks actin polymerisation. The effect of CD on nuclear
shape raised the possibility that the NE-membrane is
directly a target for the drug. To address this question, we
profited from the availability of a fluorescent CD conju-
gate: CD-BODIPY TMR (tetramethylrhodamine) to detect
CD binding-sites at the NE-membrane using fluorescence
microscopy.
Before performing live cell in situ experiments we exam-
ined the actin binding characteristics of CD-BODIPY-TMR
in vitro and in fixed cells. CD-BODIPY fluorescence was
measured in vitro at various concentrations (2–1000 nM;
fig.2A) in solutions containing fully polymerised rabbit
skeletal muscle actin at 10 μM (a concentration far above
the critical concentration for polymerisation wherein
~100% of available actin is in the polymeric form [17]).
Under these in vitro conditions a concentration depend-
ent, sigmoid shaped increase in CD-BODIPY fluorescence
was observed, which closely resembled its behaviour
when added to fixed cells at the same concentration
(fig.2A). Both in vitro and in fixed cells these results sug-
gest that the drug bound a saturable actin-binding site in
the absence of dynamic actin filament turnover. In a sec-
ond, in vitro assay we tested CD-BODIPY's fluorescence
characteristics in the presence of polymerised actin and
lantruculin A (LatA). LatA specifically binds G-actin (1:1),
but not F-actin, and the resulting reduction in available
monomers, shifts the dynamic steady-state equilibrium
for actin filament formation towards depolymerisation
[18]. In the presence of a constant concentration of actin
(~10μM) and CD-BODIPY (50 nM), the effect of increas-
ing concentrations of LatA was a net reduction in CD-
BODIPY fluorescence (fig.2B). This effect was linear at
drug concentrations between 1–10μM, and half-maximal
at ~5μM, reflecting the predicted stoichiometry given the
concentration of actin present. Since only the concentra-
tion of LatA was modified in this assay, the three-fold
BMC Cell Biology 2006, 7:23 http://www.biomedcentral.com/1471-2121/7/23
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Treatment of cells with actin interfering drugsFigure 1
Treatment of cells with actin interfering drugs. HeLa cells were treated for 30 min at 37°C with the actin-binding drugs 
LatA (1μM), CD (1μM) Jaspl (200 nM), or vehicle (DMSO) and then stained with Hoechst 33342. Nuclear shape phenotypes 
were distinguished ("normal/round" or "irregular" nuclei) and counted by widefield microscopy. (A) The bar graph shows the 
percentage of normal nuclei (white) versus irregular nuclei (grey) measured from two independent experiments (see methods). 
(B) The panel shows an example of normal nuclei (after treatment with vehicle) compared with irregular nuclei following drug 
treatments. Scale bar: 5μm
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CD-BODIPY binds free-barbed-end actin protomers in vitroFigure 2
CD-BODIPY binds free-barbed-end actin protomers in vitro. (A) Concentration dependency of CD-BODIPY fluores-
cence in polymerised actin solutions (heavy dashed line, filled circles). The drug's dose dependent fluorescence in fixed cells 
(HEK293) is also shown (filled squares, fine dashed line). All data are normalised to fluorescence maxima at 1μM CD-BODIPY. 
(B) Measurement of the concentration dependent effect of LatA on CD-BODIPY fluorescence (50 nM) in the presence of pol-
ymerised actin. Data points are normalised to the fluorescence measured in unpolymerised samples containing 10μM (ATP. 
actin). Note that in the absence of LatA, CD-BODIPY fluorescence in the presence of polymerised actin is three-fold higher 
than that measured in unpolymerised actin solutions. (C) (i) fluorescence of 50 nM CD-BODIPY in the presence of increasing 
[actin] in the presence of ATP (circles); (ii) corresponding FITC-actin fluorescence (squares) measured from the same sample 
fields. Fluorescence data are normalised to the average signals measured in unpolymerised conditions ([actin]) = 8.8μM). Graph 
(iii) shows the ratio of normalised CD-BODIPY fluorescence to normalized FITC-actin fluorescence. The border between the 
two shaded areas indicating conditions favouring short (light grey shading) or long (dark grey) actin polymers defines the critical 
concentration expected for actin polymerisation in the presence of 50 nM CD [17]. In all graphs vertical bars show S.E.M. from 
triplicate samples.
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change in CD-BODIPY fluorescence could be explained
by fluorescence enhancement of the drug's tetramethyl-
rhodamine (TMR) moiety, upon binding to free-barbed-
end protomers. Fluorescent enhancement resulting from
TMR-drug binding to actin has been previously reported
for TMR-phalloidin, and attributed to the sensitivity of
TMR-X moiety in proximity to the hydrophobic environ-
ment of actin protomers [19,20]. This increase in fluores-
cence is a favourable property for the drug's use as a probe
because it enhances specific signal detection. In light of
this fact, we next examined CD-BODIPY fluorescence in a
pure solution of actin around the critical concentration.
Accordingly, we found that CD-BODIPY (50 nM) fluores-
cence peaked in pure solutions of actin at the critical con-
centration (~1.1μM; [17]) as shown in fig.2C(i)).
Furthermore, relative to the total amount of actin present
(fig.2C(ii)), CD-BODIPY fluorescence was diminished at
levels at and above the critical concentration (fig.2C(iii)).
In contrast, below the critical concentration the CD-BOD-
IPY fluorescence relative to total actin present was at its
highest levels, consistent with the view that free-barbed-
end protomers and tri-meric nucleation complexes were
most abundant at these concentrations (fig.2C(iii)). These
in vitro results strongly suggested CD-BODIPY's utility as
a fluorescent probe to detect CD binding sites in situ.
For in situ visualisation inside living cells we used CD-
BODIPY at very low concentrations (5–50 nM) relative to
the drug's expected affinity for actin. This provided suffi-
ciently strong staining allowing for signal detection, with-
out interfering with actin polymerisation [21]. Within a
few minutes after adding the fluorescent drug to the incu-
bation medium we observed CD-BODIPY accumulation
into plasma membrane microspikes that were co-labelled
with fluorescent actin expressed in the same cell (fig.3A).
This observation was consistent with the expected binding
properties of CD-BODIPY, because these tiny sub-cellular
compartments are characteristically concentrated with
polymerising actin [22] and are highly sensitive to disrup-
tion by cytochalasin D. In a separate series of experiments,
HeLa cells stably expressing the transmembrane nuclear
pore complex (NPC) protein POM121 conjugated to the
green fluorescent protein (GFP) [23] (H-PomGFP cells)
were co-stained with CD-BODIPY. In these experiments,
CD-BODIPY was observed to accumulate strongly in the
deep perinuclear cytoplasm and across NE-membranes in
almost all cells analysed. Based upon the distribution of
the POM121 NPC signal, CD-BODIPY was localised to
the NE-membrane however we did not detect a strict sig-
nal co-localisation pattern (fig.3B). Indeed across small
stretches of the NE-membrane we discerned both positive
and negative signal correlation among adjacent, near-sub-
resolution regions of interest between CD-BODIPY and
POM121-GFP fluorescence (fig.3B, lower panel, white
arrow). Thus, CD-BODIPY labelling formed a discontinu-
ous pattern comprising punctuate accumulation along the
nuclear membrane. This staining pattern suggests strongly
that CD-BODIPY binds directly at the NE-membrane, but
is not strictly co-localised with NPCs.
Actin accumulates at the cytoplasmic phase of NE-
membranes
In H-PomGFP cells we observed ~70% of NE-membrane
POM121-GFP signal was spatially coincident with CD-
BODIPY signal, a value significantly greater (P < 0.01; n =
5) than that measured from control experiments (dextran
injection; see methods; fig.4A). This suggests the presence
of free-barbed-end actin-filaments in close proximity to
the NE-membrane. To rule out the possibility that this
accumulation of NE-membrane associated actin was due
to treatment with CD-BODIPY, we repeated the same
imaging protocol and quantification method using H-
PomGFP cells labelled by cytoplasmic microinjection of
fluorescent actin (Alexa568). Within minutes of microin-
jection into cell cytoplasm, the fluorescent (Alexa568)
actin was detected in a ring pattern around cell nuclei sim-
ilar to that observed for CD-BODIPY. A series of experi-
ments revealed ~37% of green POM121-GFP signal was
coincident with cytoplasmically micro-injected actin
(fig.4A) a value still significantly (P < 0.01; n = 5) higher
than that measured in systematic control experiments. We
next investigated the sub-cellular distribution of citrin-
actin [24] expressed in a HeLa cell line stably expressing
red fluorescent nuclear lamin A (LA-dsRed). Citrin-actin
accumulated at the cell cortex (fig.4B and 4C; red arrows),
and in a faint, but distinct ring-like pattern close to the
NE-membranes (fig.4B and 4C; green arrows). Delineated
by the nuclear lamina labelling, the perinuclear actin sig-
nal was observed in both the reconstructed XY (fig.4B)
and orthogonal YZ (fig.4C; red arrow) section views. In
these reconstructions the fluorescence intensity of perinu-
clear actin appeared brighter than the actin fluorescence
detected in the nearby cytoplasm (fig.4B right panel). The
three-dimensional analysis of signal coincidence revealed
that about 65% of LA-dsRed nuclear lamina signal was
significantly (P < 0.01; n = 5) co-incident with citrin-actin
(fig.4A).
Further, we observed that the distribution of micro-
injected fluorescent actin in 3D rendered reconstruction
from through stack image series comprises a punctuate
discontinuous labelling across the NE-membrane [see
Additional file 1]. A pattern strongly analogous to that
observed using cells stained with CD-BODIPY and
POM121-GFP [see Additional file 2].
The live cell imaging experiments suggested that cytoplas-
mically injected actin rapidly accumulated at the NE-
membrane. Therefore, we presume that freely diffusing
actin in the cytoplasm had direct access to the perinuclear
BMC Cell Biology 2006, 7:23 http://www.biomedcentral.com/1471-2121/7/23
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Compartmentalisation of CD-BODIPY inside living cellsFigure 3
Compartmentalisation of CD-BODIPY inside living cells. (A) Shows a YZ optical section through a 3D confocal stack 
recorded from a single living HeLa expressing citrin-actin and stained with 50 nM CD-BODIPY for 20 minutes. The top and 
middle rows show corresponding CD-BODIPY and citrin-actin channels respectively, whereas the bottom shows the corre-
sponding overlay image. Note the co-compartmentalisation of CD-BODIPY and the citrin-actin at a microspike protruding 
from the top of the cell (red cursor). Scale bar 5μm. (B) Single confocal optical section through a H-PomGFP (green) living cell 
co-stained with 50 nM CD-BODIPY (red) and the corresponding colour overlay image. Note strong accumulation of CD-BOD-
IPY at the perinuclear proximity and the presence co-incident with NE-membrane labelling. Bottom panels show detail from 
selected region (white rectangle) highlighting where in this representative example NE-membrane signals were clearly distin-
guished from cytoplasmic staining revealing a clear view of compartmentalisation between CD-BODIPY and POM121 (white 
cursor). Scale bars: top row: 5μm; bottom row: 2μm.
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Perinuclear actin revealed with a range of actin staining methodsFigure 4
Perinuclear actin revealed with a range of actin staining methods. (A) Relative measure of actin accumulation at the 
NE inside living cells. Average values (n = 5 cells in each case) were calculated (see methods) from normalised intensity values 
mapped in three-dimensional image stacks recorded from living cells labelled using various protocols to reveal actin and NE-
membranes. Results show averages of the percentage of NE-membrane label (either POM121-GFP or dsRed-laminA) that was 
not distinguishable in spatial coordinates (given resolution limits) from actin labelling probes (actin568, CD-BODIPY, citrin-
actin). Averaged results (n= 5 cells) were compared (P < 0.01; student t-test) with those calculated from samples labelled by 
cytoplasmic micro-injection of dextran-rhodamine inside cells expressing POM121-GFP (B) Spinning disk confocal image of sin-
gle living HeLa cell expressing lamin A dsRed (upper panels) and citrin-actin (lower panels). The XY optical section shows accu-
mulation of cortical actin at the plasma membrane (red cursor). The green cursor indicates the faint perinuclear actin 
accumulation. The right panels show detail from the regions of interest indicated by the white-line dashed boxes in the left-
hand panels. Scale bars: left panels 7μm; right panels 0.5μm. (C) Shows the YZ section view reconstructed from the same 3D 
through-stack dataset as (B) above. The red and green cursors show cortical and perinuclear actin accumulation as for (B). 
Note also the presence of an interphase nuclear invagination where dsRed-LaminA and citrin-actin both intrude upon the 
nuclear volume (white arrowhead). Scale bars: 7μm.
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Actin polymerisation around isolated, differentiated, intact nuclei in vitroFigure 5
Actin polymerisation around isolated, differentiated, intact nuclei in vitro. (A) Isolated rat liver nuclei were incu-
bated for 1 h at 37°C with 500 nM actin Alexa488 under polymerising conditions and then imaged by fluorescence microscopy. 
(a): Fluorescent actin-Alexa488 assembled around isolated whole intact nuclei (left panel). The nuclei were identified by DIC 
imaging (right panel). (b) Shows representative examples of nuclei that were pre-incubated with mAb414 (see methods) and 
subsequently subjected to the actin polymerisation assay. After this treatment, the nuclei did not polymerise actin at their cyto-
plasmic surface (fluorescent image (left panel) has been contrast enhanced in order to reveal background staining of nuclei as 
well as dim residual actin filaments) (left panel: actin Alexa488 image and DIC on the right panel). (B) The effect of various anti-
bodies on the polymerisation of actin around isolated nuclei. Note how both mAb414, and antibodies against Nuance or the 
non-specific nuclear transport inhibitor wheatgerm-agglutinin WGA significantly reduced actin polymerisation. By contrast 
anti-Emerin had no significant effect compared with anti-c-Myc (three independent experiments 50 nuclei/condition).
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actin pool. We therefore used an in vitro actin polymerisa-
tion assay to examine the gross formation of actin poly-
mers around highly purified nuclei, freshly isolated from
rat liver hepatocytes. Intact hepatocyte nuclei were incu-
bated in the presence of actin under conditions favouring
actin polymerisation. Under these conditions we found
that fluorescent actin polymerised in a halo around iso-
lated intact nuclei. Testing several actin concentrations we
observed this phenomenon at concentrations as low as
100 nM actin (~10% of the expected critical concentra-
tion; data not shown). In the presence of only 500 nM flu-
orescent actin (just half the critical concentration expected
for in vitro conditions) we observed polymerised, fluores-
cent actin microfilament bundles in a halo around
approximately 80% of individual nuclei (fig.5A(a)). Pre-
incubation of intact nuclei with antibody against FXFG-
repeat containing nucleoporins (mAb414); and non-
nucleoporin (anti-nuance, antibody targeting ONM non-
nucleoporin nesprin/nuance) both resulted in a decrease
in the number of nuclei displaying actin filaments
(fig.5B). Furthermore, the non-specific nuclear transport
inhibitor wheat germ-agglutinin (WGA) also significantly
reduced the percentage of nuclear actin halos (Mann-
Whitney test: P < 0.05). By contrast, pre-incubation with
antibodies to INM proteins (anti-Emerin, a protein
epitope not accessible at the surface of intact nuclei) had
no significant effect compared with both negative (no
added antibody) and positive (anti-c-Myc) control condi-
tions (Mann-Whitney test: P > 0.05). These experiments
strongly suggest that actin polymerisation is localised to
the cytoplasmic phase of intact isolated NE-membranes in
vitro.
Discussion
Previous studies using conventional approaches in fixed
cells have described evidence for perinuclear actin in a
variety of cell types including giant polyploid silk gland
epithelial cells [25], insect cells [26], amobea [27] and
fungi [28]. In vertebrate tissue cells a perinuclear actin
basket, revealed by phalloidin has also been reported
[29,30]. However, these studies were limited to a visuali-
sation of actin after cell fixation, and lacked information
on actin polymerisation, in situ, ie inside living cells. In
the current study, we provide evidence for perinuclear
actin polymerisation using spinning disk confocal micro-
scopy. Our results show that inside intact living cells actin
polymerises at NE-membranes, in a manner involving
free-barbed-end protomers and through yet unidentified
molecular components at the cytoplasmic face of the NE-
membrane.
Actin is one of the most abundant proteins in eukaryotic
cells and this exacerbates detection of specifically local-
ised subcellular compartments or gradients, because the
vast majority of measured signal is derived from actin
bound in very bright structures (e.g.: stress fibers) or G-
actin. Evidently, this is less problematic for studies inves-
tigating actin polymerisation in more accessible regions
for imaging e.g. actin polymerisation at the leading edge
of the plasma membrane [8,31-33]. By contrast, in the
current study our interest was focused on perinuclear
actin. To visualise actin in the perinuclear cytoplasm we
used spinning disk confocal microscopy in order to max-
imise three-dimensional resolution. With this approach it
was striking that a nuclear actin ring was observed using
several types of probes for visualisation, but was not read-
ily observed using conventional wide-field imaging. The
need for spinning disk confocal microscopy followed by
deconvolution can explain why the perinuclear actin ring
has until now not been described inside living cells.
Using confocal imaging our results reveal that cytoplasmic
micro-injection led, within minutes, to accumulation of
fluorescent actin at the NE-membrane. This rapid accu-
mulation of micro-injected actin fits with the idea that the
perinuclear pool of actin and cytoplasmic actin are in
dynamic equilibrium. One mechanism for cytoplasmic G-
actin to interact with the perinuclear actin pool could be
that the latter concentrates actin binding sites that present
free-barbed-ends to which free cytoplasmic G-actin may
further associate. Certainly, our results using CD-BODIPY
are highly consistent with this view. We have shown that
CD-BODIPY that binds free-barbed-end actin with high
affinity in vitro, yields a labelling pattern coincident with
the NE-membrane in situ. Pertinently, the NE-membrane
associated CD-BODIPY signal was observed to extend into
the perinuclear cytoplasm, but never into the nuclear
matrix, suggesting that the signal is continuous with the
cytoplasmic actin cytoskeleton. However, given the sensi-
tivity and resolution limits of optical microscopy this does
not rule out the possibility that actin polymerisation
could be physically located at the inner-face of the NE-
membrane.
A recent study has shown that microinjected actin is local-
ised to the NE-membrane of starfish oocytes, in a ring pat-
tern around the nucleus [34] analogous to our findings
presented in the current work. This study showed that a
transient burst of actin polymerisation occurs upon NE-
membrane fenestration marking the beginning of nuclear
envelope breakdown (NEBD), and M-phase progression.
Using ultra-structural electron microscopy Lenard et al.
localised actin polymerisation to the inner face of the NE-
membrane in accordance with their model. Our current
study using high-resolution multidimensional light
microscopy raised the same question: i.e. whether polym-
erisation occurs at the inner-(nuclear matrix) or outer-
(cytoplasmic) face of the NE-membrane. By contrast to
the actin polymerisation upon NEBD, our results suggest
that perinuclear actin polymerisation in interphase nuclei
BMC Cell Biology 2006, 7:23 http://www.biomedcentral.com/1471-2121/7/23
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of metazoan cells is driven from physical interactions at
the cytoplasmic side of the NE-membrane. In vitro, we
observed long actin filaments propagating outwards from
intact nuclei isolated from differentiated rat liver cells,
and incubated under conditions favouring actin polymer-
isation. Furthermore, nuclei were intact and apparently
impermeable (in the absence of GTP) to actin because we
never observed fluorescent actin inside the nuclear matrix.
Additional argument supporting the view that actin binds
the cytoplasmic face of isolated nuclei was derived from
our results indicating that actin polymerisation was
strongly diminished in the presence of antibodies (or lec-
tin) targeting ONM proteins, but not INM. Both antibody
(mAb414) and lectin targeting ONM nucleoporins inhib-
ited actin polymerisation as strongly as anti-nesprin (a
non-nucleoporin target). Therefore we hypothesise that
these effects were due to molecular steric hindrance of a
cytoplasmic ONM actin binding site closely juxtaposed
with nucleoporins and/or non-nucleoporins. This inter-
pretation is also consistent with our observation that no
actin labelling method yielded precise co-localisation
with the nucleoporin POM121. Despite the uncertainty
concerning whether nucleoporins and/or non-nucleop-
orins provide the actin binding site, our results do demon-
strate that intact interphase nuclei support actin
polymerisation at the cytoplasmic face of ONM. Interest-
ingly, previous studies on isolated patch-clamped nuclei
have provided evidence that NPC ionic permeability
measured by electrophysiology can be modulated by actin
added to the ionic bathing solution suggesting that the
effect involved cytoplasmic ONM interactions [35]. More-
over, a role for NPC-associated cytoplasmic cytoskeleton
filaments in regulation of NPC transport functions has
been postulated [14]. In either case, taken together with
our current results, these hypotheses provide for a plausi-
ble functional impact linking the signalling milieu of the
cytoplasmic actin cytoskeleton with NPC structure and
function.
Conclusion
A dynamic pool of actin filaments is linked to the cyto-
plasmic face of nuclei in metazoan cells during inter-
phase. Further studies will now aim at the identification of
the factor (or factors) responsible for targeting actin
polymerisation to the NE-membrane, and precisely defin-
ing the functional implications therein.
Methods
Cell lines and cell culture
HeLa (ATCC) were cultured in complete DMEM (DMEM
Glutamax (Gibco BRL), 10% FCS, 100 U ml-1 streptomy-
cin, 100 μg ml-1 penicillin) at 37°C; 5% CO2. H-PomGFP
cells: nuclear pore labelling in HeLa cells was achieved by
transfecting cells (Fugene6, Boehringer-Mannheim) with a
plasmid containing POM121-GFP (kind gift of E. Hall-
berg, University College, Huddinge). Citrin-actin (kind
gift of A. Hoppe, University of Michigan) was expressed
where stated in HeLa cells using the same transfection
method. Citrin-actin is a fusion construct of actin with an
improved YFP variant [36]; the plasmid used in the cur-
rent study has been described elsewhere [24].
Constructing HeLa cells stably expressing LaminA-dsRed
Prelamin A cDNA cloned into pSVK3 plasmid was ampli-
fied by PCR, with an EcoRI restriction site engineered at
the 5' end of the sense primer (5'-GCG AAT TCT ATG GAG
ACC CCG TCC CAG CGG-3') and a KpnI restriction site
engineered at the 5' end of the antisense primer (5'-GC
GGT ACC TTA CAT GAT GCT GCA GTT CTG-3') (as
described in [37]). The reaction product was digested with
EcoRI and KpnI and ligated in frame into purified, line-
arised pDsRed-C1 (Clontech, Inc, Palo Alto, CA) after
digestion with EcoRI and KpnI. HeLa cells cultured to 80%
confluency were transfected in chamber slides with Lipo-
fectamine PLUS (Life Technologies, Inc., Gaithersburg,
USA.), following the manufacturer's instructions. Stable
transfected cells were selected in the presence of antibiotic
(1 mg ml-1 G418; Gibco Life Technologies Ltd). Selection
of dsRed-positive cells was performed with FACS (fluores-
cence-activated cell sorter) analysis.
Actin-binding drug treatment of HeLa cells
HeLa cells were grown on cover-slides and treated for 30
minutes with cytochalasin D 1μM (Sigma), latrunculin A
1μM (Molecular Probes) or jasplakinolide 200 nM
(Molecular Probes) at 37°C. Then cells were washed with
PBS, fixed for 5 minutes with 3%PFA at RT, stained with
Hoechst 33342 (Sigma-Aldrich) (10 min, 0.001 mg ml-1)
and mounted on slides. The nuclei were imaged with a
widefield microscope (see below) and nuclear shape was
evaluated and counted in two independent experiments.
For each experimental condition at least 150 nuclei from
at least ten microscopic fields were counted.
In vitro actin polymerisation assay on isolated rat liver 
nuclei
Nuclei were purified from rat liver [38]: Rats were asphyx-
iated with CO2, and were then decapitated. The livers were
isolated, placed into ice-cold low sucrose buffer (0.25 M
sucrose, 50 mM Tris-HCl pH 7.5, 25 mM KCl, 5 mM
MgCl2, 1 mM DTT, 0.5 M PMSF and 1 μg ml-1 leupeptin/
aprotinin/pepstatin) and minced. Then, 1 volume of
minced liver and 2 volumes of the same buffer were
homogenised in a Potter-Elvehjem homogeniser (0.025
cm clearance) for 15 full strokes at 1,700 rpm. The
homogenate was filtered through 4 layers of cheese cloth
and centrifuged at 800 g for 15 minutes at 4°C. 1 volume
of loose pellet was mixed with 2 volumes of high sucrose
buffer (2.3 M sucrose, 50 mM Tris-HCl pH 7.5, 25 mM
KCl, 5 mM MgCl2, 1 mM DTT, 0.5 M PMSF and 1 μg ml-1
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leupeptin/aprotinin/pepstatin) before overlaying 1 part of
high sucrose buffer with 5 parts of the initial mixture and
ultra-centrifuged at 28000 rpm for 1 hour at 4°C in a SW-
28 rotor (Beckman, USA). The nuclei containing pellet
was re-suspended in the low sucrose buffer and was again
homogenised with 2 full strokes as described above. This
homogenate was centrifuged at 800 g for 15 minutes at
4°C and the pellet contained the highly purified rat liver
nuclei. These nuclei were re-suspended in the low sucrose
buffer, and aliquots were stored at-80 °C. The number of
nuclei was determined by measuring the OD260 (OD260 =
1 equals 3 × 106 nuclei). The quality and entireness of iso-
lated nuclei was assured by light microscopy.
Fluorescent actin-Alexa488 (Molecular Probes) in G-
buffer (0.2 mM ATP, 0.2 mM CaCl2, 1 mM DTT, 10 mM
Tris-Hcl, pH 8) was polymerised at 0.5 μM by addition of
a 1:9 dilution of 10x KMEI (500 mM KCl, 10 mM MgCl2,
10 mM EGTA, 100 mM imidazole, pH 7) in the presence
of 1 unit of isolated rat liver nuclei (~3 × 106 nuclei). Iso-
lated nuclei were pre-incubated with antibodies overnight
at 4°C with continuous, gentle agitation. Antibodies used
in this assay were mAb414 (Eurogentec, 1/1000), mAb
anti-Nuance (kind gift of A. Noegel, University of
Cologne; 1/10), anti-Emerin (kind gift of H. Hermann,
DKFZ Heidelberg; 1/200) and mAb anti c-Myc (9E10
Santa-Cruz Biotechnologies, 1/1000). Additionally, we
incorporated the non-specific nuclear transport inhibitor
wheatgerm agglutinin (Invitrogen) in this assay. An aliq-
uot of the reaction mix was sealed under a glass cover slip
(coated with 2% cold water fish skin gelatin) on a micro-
scope slide and then incubated for 1 hour at 37°C to
allow time for actin polymerisation to occur. Finally, the
number of nuclei displaying actin microfilaments was
counted using a widefield microscope.
Microinjection
Single cells were cytoplasmically microinjected with
either 10 μM actin-Alexa568 (Molecular Probes) or 2.5
mg ml-1 dextran-rhodamine 70 kDa (Molecular Probes)
using a Femtojet/Injectman micromanipulator (Eppen-
dorf, Hamburg, Germany).
CD-BODIPY in vitro measurements
Purified, native and fluorescent (FITC) conjugated rabbit
skeletal muscle actin (Cytoskeleton, Denver, U.S.A.) in 2μl stock aliquots (10 mg ml-1; 222 μM) containing 2 mM
Tris-HCl, 0.2 mM CaCl2, 0.2 mM ATP, 0.5 mM DTT, 2%
sucrose, and 0.005% NaN3 (pH 8) were prepared at work-
ing dilutions (0.5–0.75 mg ml-1; 11–17 μM) by addition
of low salt buffer (5 mM Tris-HCl, 0.2 mM Na-ATP, 0.5
mM DTT, 0.2 mM CaCl2, pH 8). For each experiment a
single fresh actin stock was prepared. Drugs were added,
yielding the final concentrations stated. Samples were vig-
orously mixed by pipetting, vortexed and then left on ice
for 1 hour before centrifugation (100,000x g, 4°C, 30
minutes). Supernatants were added to 5x concentrated
high salt polymerisation buffer giving final concentrations
of 100 mM KCl and 10 mM Mg-ATP. After mixing, a 5 μl
aliquot was sealed under a glass cover slip on a micro-
scope slide and incubated at 37°C for at least 3 hours to
allow actin to fully polymerise to a steady state [17] before
semi-quantitative observation using fluorescence micros-
copy. Each experiment (triplicate samples) was performed
at least twice yielding comparable results.
Image acquisition, processing, and analysis
For live cell imaging, cells cultured on 35 mm glass bot-
tom dishes (MatTek Corporation, USA) were exchanged
into OptiMEM (Gibco BRL), and transfered to the micro-
scope stage that was maintained at 37°C (Carl Zeiss "Tem-
pcontrol 37–2 digital" incubator support). For
experiments using CD-BODIPY, experimental medium
was freshly prepared by serial dilution of a 1 mM stock
solution (DMSO) to the stated final concentrations (2–50
nM). Facile and sufficient staining of cells was achieved by
incubation of cells in this solution for 20 minutes before
recordings began. In the presence of such very low con-
centrations, we found that cells could be maintained for
several hours, or even days, without any deleterious
effects. Using bright-field observation, we routinely
ensured that observed cells were flat, adherent and
healthy. Fluorescent imaging was performed using a high-
speed spinning disk confocal system (UltraView RS Per-
kin-Elmer, USA) equipped for dual wavelength excitation
(Kr-Ar laser; 488 nm and 568 nm) and axial z-stack sam-
pling (PI objective piezo-drive). The system was built
around a Carl Zeiss (Germany) Axiovert 200 microscope.
Cells were visualised using a Hamamatsu (Japan) ERII
camera (exposure time 200 ms) using a 100x NeoFluor NA
1.3 oil-immersion objective (Carl Zeiss). Fast axial
(through-stack) sampling used a piezo-objective drive
stepping at 200 nm throughout the cell volume.
For analysis, all axial image datasets were treated identi-
cally. First using geometric light reconstruction (deconvo-
lution) based on a calculated point-spread-function,
followed by a "maximum likelihood estimate" (MLE) iter-
ative algorithm (Huygens software; Scientific Volume
Imaging, Netherlands), in "Nipkow-disk" mode with
parameters for the Yokagawa CSU-22 scan head. The
deconvolved 3D through-stack results were then analysed
for signal coincidence using the "Coloc" plug-in of Imaris
(Bitplane, Switzerland). For all results we set a threshold
based on the averaged background signal detected outside
the region of interest in the channel used for NE-mem-
brane detection (POM121-GFP, or dsRed-Lamin), such
that the threshold identified a binary mask region deline-
ating the NE-membrane signal. The second channel
(Alexa568-actin, citrin-actin, or CD-BODIPY-TMR) was
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then similarly thresholded and masked. Quantification of
signal co-incidence between two channels was then meas-
ured as a function of the percentage of pixels detected in
the NE-membrane signal channel that were also positive
for binary masked pixels derived from the actin depend-
ent signal. This quantification process was applied to each
image in any given stack, yielding an estimate of three
dimensional signal co-incidence in a given cell. As a sys-
tematic control for this 3D signal coincidence we used
exactly the same acquisition and analysis protocol except
H-PomGFP cells were microinjected cytoplasmically with
red fluorescent Alexa568-dextran. This provided us a rela-
tive measure of the microscope's ability to distinguish the
NE-membrane (green) from diffusible non-specific cyto-
plasmic signal (red). On average (n = 5), throughout the
imaged 3D volume we found that just ~12% of pixels con-
taining specifically localised NE-membrane signal were
spatially coincident with pixels also positive for red dex-
tran signal. Given that the dimensions of the NE-mem-
brane were below the optical resolution limits of the
microscope, and that all two-color, three-dimensional
analysis used the same imaging hardware/analysis this
value served as a systematic threshold limit below which
the NE-membrane and cytoplasmic signals could be con-
sidered "non-coincident".
Images of isolated intact nuclei for the in vitro actin
polymerisation assay used a standard Zeiss Axiovert 200
M microscope equipped with a 40x objective, NA 1.3. The
microscope was controlled by Till Vision (Till photonics,
Germany) designed for fast live cell imaging and
equipped with a xenon lamp, polychromator (Polychro-
meIV) for wavelength selection and a Till Photonic Imago
QE CCD camera.
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